First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice
The aim is to evaluate the efficacy of the first-line rituximab-containing therapy of B-cell lymphoproliferative diseases in Russian clinical practice between 2014 and 2017. Materials and methods. In the post-authorisation multicenter study EQUILIBRIUM were included 1 thousand patients aged from...
Guardado en:
Autores principales: | Lali G. Babicheva, Irina V. Poddubnaya |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8c86a1abee24252a6ffdffa30b488a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparación entre CHOP-like y R-CHOP en pacientes con linfoma no Hodgkin difuso de grandes células B y folicular: 10 años de experiencia del Hospital de Clínicas de Montevideo, Uruguay
por: Oliver,Carolina, et al.
Publicado: (2013) -
New developments in the treatment of follicular lymphoma/ marginal zone lymphoma (according to the Congress of the American Society of Hematology – 2020)
por: Lali G. Babicheva
Publicado: (2021) -
COMPLEX ESTIMATION OF BRONCHOPULMONARY SYSTEM IN PATIENTS WITH HODGKINS LYMPHOMA
por: Yu. N. Obgolts, et al.
Publicado: (2012) -
Hodgkin's lymphoma
por: E. A. Demina, et al.
Publicado: (2020) -
Ocurrencia de leucemia mieloide crónica y linfoma no Hodgkin en un mismo paciente: Caso clínico
por: Morales F,Eugenia, et al.
Publicado: (1999)